NCT03519295 2025-06-27
SCARCE
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2 Completed
Clinical Trials
12 trialsNCT00324415 2025-05-30
Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer
AIDS Malignancy Consortium
Phase 2 Completed
NCT00316888 2023-06-29
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT03690921 2023-06-29
Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02560298 2023-06-22
InterAACT
Eastern Cooperative Oncology Group
Phase 2 Unknown
NCT00003652 2021-02-17
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
UNICANCER
Phase 3 Completed
NCT00955240 2020-02-11
Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer
UNICANCER
Phase 2 Terminated
NCT00003596 2017-01-04
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT02051868 2015-11-04
InterAACT
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT00002854 2015-08-26
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
City of Hope Medical Center
Phase 1 Completed
NCT00025090 2013-08-26
Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00068744 2012-09-24
Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2/3 Terminated